Company profilePharmaceutical#733 of 1,318 in Pakistan✓ No DRAP alerts

Biocare Pharmaceutica DSL: 05-353-0063-032069D

Pharmaceutical company · 12 brands · 17 molecules

Ranked #22 of 25 companies in Other Anti-Baterials

12 registered products 12 pharmaceutical brands 17 distinct molecules 0 DRAP alerts

Company overview

12
registered products
12
pharmaceutical brands
17
distinct molecules
1
therapeutic classes
0
DRAP alerts

Biocare Pharmaceutica DSL: 05-353-0063-032069D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 12 product registrations across 17 distinct molecules. Its portfolio is concentrated in Other Anti-Baterials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Biocare

14 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

11
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202611

Top molecules by brand count

Piperacillin ...... 3 Gm1 brand
Vancomycin ...... 1000 Mg1 brand
Microemulsion Cyclosporin A 100Mg ...... 100 Mg1 brand
Microemulsion Cyclosporin A 25Mg ...... 25 Mg1 brand
Microemulsion Cyclosporin A ...... 50 Mg1 brand
Piperacillin ...... 2 Gm1 brand
Piperacillin ...... 4 Gm1 brand
Colistin ...... 150 Mg1 brand

Therapeutic classes

Other Anti-Baterials · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official17 products · Rs 365.58 – Rs 15,693.12
Median across source: Rs 1,576.79

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BOSCH PHARMACEUTICALS (PVT) LTD. holds 152 molecules not in this portfolio
AmikacinAmlodipineAmoxicillinAmoxicillin SodiumAmoxicillin …50Mg Clavulanic Acid 12.5 MgAmoxycillin
Global Pharmaceuticals Pakistan holds 142 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin
Biogen Pharma holds 9 molecules not in this portfolio
AtracuriumCarbamazepineCholecalciferolClopidogrelEflornithineHydrocortisone

Get the full profile for Biocare

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.